Rupert Page

The SANAD II study of the effectiveness and cost-effectiveness of valproate versus levetiracetam for newly diagnosed generalised and unclassifiable epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial

Anthony G Marson, Girvan Burnside, Richard Appleton et al. · The Lancet · 2021 · 211 citations · Full text

Medicine, Neurology, Pharmacology +17

The SANAD II study of the effectiveness and cost-effectiveness of levetiracetam, zonisamide, or lamotrigine for newly diagnosed focal epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial

Anthony G Marson, Girvan Burnside, Richard Appleton et al. · The Lancet · 2021 · 191 citations · Full text

Medicine, Neurology, Pharmacotherapy +15

Genetic dysfunction of <i>MT-ATP6</i> causes axonal Charcot-Marie-Tooth disease

Robert D. S. Pitceathly, Sinéad M. Murphy, Ellen Cottenie et al. · Neurology · 2012 · 111 citations · Full text

Life Sciences, Genetics, Neurology +17

Exploring the Touch and Motion Features in Game-Based Cognitive Assessments

Jittrapol Intarasirisawat, Chee Siang Ang, Christos Efstratiou et al. · Proceedings of the ACM on Interactive Mobile Wearable and Ubiquitous Technologies · 2019 · 22 citations · Full text

Medicine, Behavioral Sciences, Psychology +17

Digital Care in Epilepsy: A Conceptual Framework for Technological Therapies

Rupert Page, Rohit Shankar, Brendan McLean et al. · Frontiers in Neurology · 2018 · 17 citations · Full text

Medicine, Health Informatics, Neurology +14